diabetes

The poor prognosis of critical limb ischemia related to sub treatment

Original title:&nbsp;Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence.&nbsp;Reference:&nbsp;Reinecke H et al. Eur Heart J. 2015; Epub ahead of print. &nbsp; This work included 41882 patients retrospectively from health insurance in Germany admitted with diagnosis of peripheral vascular disease between 2009 and 2011 and followed until 2013. Patients<a href="https://solaci.org/en/2015/02/20/n-5006/" title="Read more" >...</a>

Impact of kidney function on TAVI outcome

Original title:&nbsp;Impact of chronic kidney disease on the outcome of transcatheter aortic valve implantation: results from the FRANCE 2 Registry.&nbsp;Reference:&nbsp;Atsushi Oguri, et al. EuroIntervention 2015;10:e1-9 Globally, 13% of patients present kidney failure, which has been associated to a worse evolution not only of TAVI outcomes but also of other cardiovascular intervention outcomes. Most studies, including<a href="https://solaci.org/en/2015/02/19/n-4999/" title="Read more" >...</a>

Greater platelet reactivity in diabetic patients receiving DES and clopidogrel

Original title:&nbsp;Impact of diabetes mellitus and metabolic syndrome on acute and chronic on-clopidogrel platelet reactivity in patients with stable coronary artery disease undergoing drug-eluting stent placement.&nbsp;Reference:&nbsp;Feldman L. et al. Am Heart J. 2014; Epub ahead of print. Diabetes mellitus type 2 (T2DM) or metabolic syndrome patients undergoing drug eluting stent implantation have 3 to 4<a href="https://solaci.org/en/2014/10/20/n-4761/" title="Read more" >...</a>

Thrombosis with bioresorbable scaffolds: the story of DES all over again?

Original title:&nbsp;Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry.&nbsp;Reference:&nbsp;Capodanno D et al. EuroIntervention. 2014 Jul 18. Epub ahead of print &nbsp; The GHOST-EU registry, that included 1189 patients from 10 European centers between 2011 and 2014, is now the largest registry<a href="https://solaci.org/en/2014/07/30/n-4628/" title="Read more" >...</a>

Transcatheter Aortic Valve Replacement showed better results than conventional surgery in high risk diabetic patients.

Original title:&nbsp;Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Diabetes and Severe Aortic Stenosis at High Risk for Surgery An Analysis of the PARTNER Trial (Placement of Aortic Transcatheter Valve).&nbsp;Reference:&nbsp;Lindman BR et al. J Am Coll Cardiol. 2014 Mar 25;63(11):1090-9. Diabetes is associated to greater morbidity and mortality after surgical aortic valve replacement (SAVR),<a href="https://solaci.org/en/2014/03/26/n-4369/" title="Read more" >...</a>

The complete Left Bundle Branch Block after TAVI is not associated with increased mortality at 12 months

Original title:&nbsp;Impact of New-Onset Persistent Left Bundle Branch Block on late Clinical Outcomes in Patients Undergoing Trancatheter Aortic Valve implantation with a Balloon &ndash;Expandable Valve.&nbsp;Reference:&nbsp;Urena Marina, el al. JACC Cardiovasc Interv. 2014 Feb;7(2):128-36. Percutaneous aortic valve implantation brings, sometimes the presence of permanent left bundle branch block (LBBB) that has been associated in some series<a href="https://solaci.org/en/2014/03/18/n-4348/" title="Read more" >...</a>

Ischemic versus anatomical risk. Is anyone better to help us decide therapeutically?

Original title:&nbsp;Predicting Outcome in the COURAGE Trial. Coronary Anatomy Versus Ischemia.&nbsp;Reference:&nbsp;G. B. John Mancini et al. J Am Coll Cardiol Intv 2013,&nbsp;Article in press. &nbsp; Anatomical risk, ischemic amount or a combination of both, are often factors taken into account for estimating the prognosis or choose a treatment strategy. The COURAGE study (Clinical Outcomes Utilizing<a href="https://solaci.org/en/2014/01/24/n-4180/" title="Read more" >...</a>

Unprotected trunk in diabetics: angioplasty with good long-term results but more revascularization

Original title:&nbsp;Coronary artery bypass graft versus percutaneous coronary intervention with drug-eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: D-DELTA registry.&nbsp;Reference:&nbsp;Meliga Emanuele, et al. EuroIntervention 2013; 9:803-808 Diabetes increases cardiovascular risk events because of their involvement in diffuse form of the vessels, thereby generating more events and changes in revascularization strategy<a href="https://solaci.org/en/2013/12/12/n-4152/" title="Read more" >...</a>

Infrapatellar balloon angioplasty, the easiest option and with better results in critical ischemia with tissue loss

Original title:&nbsp;Longitudinal outcomes After Tibioperoneal Angioplasty Alone Compared to Tibial Stenting and Atherectomy for Critical Limb ischemia.&nbsp;Reference:&nbsp;Shaun Reynolds et al. Vascular and and Endovascular Surgery 2013 47(7):507-512 The Infrapatellar peripheral vascular disease has increased in recent years, relating to tissue loss and amputation. The therapeutic strategy is not clear, let alone the use of stents<a href="https://solaci.org/en/2013/11/21/n-4089/" title="Read more" >...</a>

Clinical factors to help decide between angioplasty and carotid endarterectomy

Original title:&nbsp;A clinical rule (sex, contralateral occlusion, age, and restenosis) to select patients for stenting versus carotid endarterectomy: Systematic review of observational studies with validation in randomized trials.&nbsp;Reference:&nbsp;Touz&eacute; E et al. Stroke. 2013;Epub ahead of print Compared with carotid endarterectomy, angioplasty with stent is associated with an increased risk of pre- procedural stroke especially for<a href="https://solaci.org/en/2013/11/12/n-4068/" title="Read more" >...</a>

Top